The STOPP Act would amend the Controlled Substances Act to regulate tableting and encapsulating machines, and their critical parts, used to produce illicit pills. It expands definitions to include key components and adds new serialization, reporting, and registration regimes designed to curb diversion of equipment into illicit drug manufacturing.
The bill creates a National Pill Press Registry and broadens penalties for tampering with serial numbers or dealing with unregistered devices. It also sets a 120-day post-enactment effective date and allows the Attorney General to adjust timing for efficient administration.
At a Glance
What It Does
Expands the list of controlled items to include tableting and encapsulating machines and their critical parts, and imposes serialization and reporting requirements under AG regulation.
Who It Affects
Manufacturers, distributors, importers, exporters, and dealers of tableting and encapsulating machines and critical parts, plus regulators and law enforcement.
Why It Matters
It creates traceability and centralized data to deter illicit production and improve enforcement against the illegal pill press supply chain.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The STOPP Act tightens federal control over the equipment used to manufacture pills. It defines a broad category called critical parts that includes components like press punches, dies, turrets, hoppers, and other items essential to tableting and encapsulating machines.
The bill treats these components the same way it treats certain listed chemicals when it comes to monitoring and control. It also broadens what counts as a regulated transaction and adds new requirements for keeping records when these machines or parts change hands.
A key feature is serialization: manufacturers and others must identify machines and critical parts with permanent serial numbers once regulations are in place, making it harder for illicit actors to move or sell equipment undetected. The act would then require registration of machines and parts, and later registration of manufacturers, importers, exporters, and dealers, with a central National Pill Press Registry maintained by the Attorney General.
Finally, the STOPP Act strengthens penalties for serial-number tampering, unregistered devices, or dealing without registration, and it establishes an 120-day usable window after enactment for implementation, with possible extensions to help agencies administer the program efficiently.
The Five Things You Need to Know
The bill adds serialization for tableting machines, encapsulating machines, and their critical parts.
It creates a National Pill Press Registry managed by the Attorney General.
Separate registration regimes apply to machines/parts and to manufacturers, importers, exporters, and dealers.
New penalties target serial-number removal, unregistered devices, and related offenses.
The act becomes enforceable 120 days after enactment, with possible regulatory postponements.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
This section names the act the Stop the Opioid Pill Presser and Fentanyl Act (STOPP Act). It signals the scope of regulation and sets the framing for the rest of the bill by identifying its legal identifier and purpose.
Definitions Expansion
Section 102 of the Controlled Substances Act is amended to add a new term, “critical part,” covering key components of tableting and encapsulating machines. The definition includes items like press punch, die system, hopper, and other elements integral to operation, ensuring these parts fall under enhanced regulatory control alongside listed chemicals.
Regulated Transactions of Critical Parts; Effective Date
This section expands the recordkeeping and transaction reporting for tableting and encapsulating machines and their critical parts. It also provides the date from which amendments apply and allows for a phased or delayed effective date as determined by the Attorney General to ensure orderly administration.
Serialization of Certain Machines and Parts
Section 310A requires serial numbers for tableting machines, encapsulating machines, and their critical parts, affixed permanently to non-removable parts. The serialization regime is to be implemented by regulation and tied to the broader regulatory framework established in the act.
Registration of Certain Machines and Parts
Section 310B creates a registration regime for machines and critical parts, including reporting requirements to the Attorney General and recordkeeping standards. It authorizes the AG to set the scope of which items are subject to registration and how records are kept.
Registration of Manufacturers, Importers, Exporters, and Dealers
Section 310C expands registration to entities that manufacture, import, export, or deal these machines and parts. It requires annual registration, allows waivers under certain health-and-safety considerations, and sets conditions for transfer or termination of registrations, with enforcement mechanisms to ensure compliance.
Offenses; Penalties
This section broadens penalties to cover violations related to serialization and registration, including tampering with serial numbers and dealing without registration. It also introduces an affirmative defense for certain pre-enactment conditions and lays out procedures for suspension or denial of registrations and related enforcement steps.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Licensed manufacturers and dealers who implement compliant serialization and registration will operate in a clearer, regulated market with reduced risk of unfair competition from illicit providers.
- Regulators (notably the Attorney General) who gain a centralized data hub—the National Pill Press Registry—for oversight and enforcement.
- Law enforcement and public health agencies benefit from better traceability, allowing them to target illicit pill-press activity more effectively.
Who Bears the Cost
- Manufacturers and dealers who must invest in serialization and enhanced recordkeeping to stay compliant.
- Manufacturers, distributors, importers, exporters, and dealers who may face increased regulatory workload and costs to register and maintain data.
- Regulators and enforcement agencies will need resources to administer, monitor, and enforce the new system and its records.
Key Issues
The Core Tension
The central tension is whether rigorous, centralized controls on pill-press equipment will meaningfully reduce illicit manufacturing while imposing acceptable costs on legitimate industry, or whether the regulation will burden lawful commerce without fully eliminating the illicit supply chain.
The act promises stronger controls on illicit pill production by creating serial numbers and a centralized registry, but it also imposes substantial compliance costs on legitimate manufacturers and dealers. The serialization and registration requirements may require significant upfront investment in tracking systems, new compliance processes, and ongoing recordkeeping.
There are also questions about how the “critical part” definition will be interpreted in practice and how uniformly regulations will be applied across manufacturers and borders. Security and privacy considerations around the central registry, as well as the potential for regulatory overlap with existing controls, warrant careful oversight.
The 120-day transition window and possible extensions provide breathing room for implementation, but they also create a moving target for industry readiness.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.